MetaCap

Corvus Pharmaceuticals Insider Trades

NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.67-0.34 (-3.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
7 · $384.16K
Sales
0 · $0
Shares bought / sold
33.13K / 0
Net activity
Net buying $384,164

Corvus Pharmaceuticals insider activity

Over the last 12 months, Corvus Pharmaceuticals insiders reported 20 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $384,164 and sold $0 worth of stock, for net insider buying of $384,164. The most recent filing shows Arcara Jeffrey (Chief Business Officer) buying 503 shares at $10.37 on Nov 13, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CRVS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CRVS insider transactions

Corvus Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Nov 13, 2026Arcara JeffreyChief Business OfficerBuy500$5.35KForm 4
Nov 13, 2026Arcara JeffreyChief Business OfficerBuy503$5.22KForm 4
Nov 12, 2026Arcara JeffreyChief Business OfficerBuy497$5.52KForm 4
Nov 11, 2026Arcara JeffreyChief Business OfficerBuy3,000$34.38KForm 4
Jun 11, 2026Moore David ScottDirectorBuy21,700$250.24KForm 4
May 18, 2026MILLER RICHARD A MDPresident and CEOBuy1,932$23.20KForm 4
May 18, 2026MILLER RICHARD A MDPresident and CEOBuy5,000$60.25KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$31.80KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$24.60KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$37.35KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$14.47KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$14.85KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$39.00KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$41.10KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$49.05KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$30.00KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$54.15KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$187.50KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise15,000$145.50KForm 4
Jan 28, 2026Thompson Peter A.DirectorOption exercise30,000$450.00KForm 4
Jun 27, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLCDirectorSale1,176,332$4.89MForm 4
Jun 27, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLCDirectorOption exercise1,397,684$4.89MForm 4
Jun 27, 2025Thompson Peter A.DirectorSale1,176,332$4.89MForm 4
Jun 27, 2025Thompson Peter A.DirectorOption exercise1,397,684$4.89MForm 4
Jun 4, 2025Jones William BentonSee RemarksOption exercise19,357$67.75KForm 4
May 7, 2025MILLER RICHARD A MDPresident and CEOOption exercise559,073$1.96MForm 4
May 10, 2024MILLER RICHARD A MDPresident and CEOGift302,016—Form 4
May 6, 2024MILLER RICHARD A MDPresident and CEOBuy577,634$1000.00KForm 4
May 6, 2024Jones William BentonSee RemarksBuy20,000$34.62KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related